The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence
Authors:
- Rachel Angharad AbbottRARachel Angharad Abbott
- Katharine M. AclandKAKatharine M. Acland
- Mark HarriesMHMark Harries
- Michael O'DohertyMOMichael O'Doherty
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 21 (5) , 446-449
Abstract
The aim of this study was to evaluate the role of [18F] fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) as a surveillance tool in asymptomatic patients with primary cutaneous melanoma with the American Joint Committee on Cancer stage 3 disease. Thirty-four patients with primary cutaneous malignant melanoma with American Joint Committee on Cancer stage 3 disease, who underwent at least one annual surveillance PET/CT scan, were retrospectively identified from our PET Centre Database in May 2008 and their characteristics, PET/CT results and disease course were reviewed. In 20 patients with microscopic stage 3 disease at diagnosis, annual surveillance PET/CT detected two of three recurrences and detected one incidental breast carcinoma. In 14 patients with macroscopic stage 3 disease at, or subsequent to, their initial diagnosis, annual PET/CT detected four of four recurrences, detected metastases in one patient who remains asymptomatic and detected one incidental thyroid carcinoma. PET/CT seems to be a useful surveillance tool in patients with macroscopic stage 3 disease, although the numbers in this study are small. However, the role of PET/CT in patients initially presenting with microscopic stage 3 disease requires further confirmation.Keywords
This publication has 9 references indexed in Scilit:
- Verification of Musculoskeletal FDG-PET-CT Findings Performed for Melanoma StagingAnnals of Surgical Oncology, 2009
- Epidemiology of invasive cutaneous melanomaAnnals of Oncology, 2009
- Role of PET in the Initial Staging of Cutaneous Malignant Melanoma: Systematic ReviewRadiology, 2008
- Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CTBMC Medical Imaging, 2007
- Detection of Metastases in Patients with Cutaneous Melanoma Using FDG-PET/CTJournal of International Medical Research, 2007
- Whole body positron emission tomography in follow-up of high risk melanomaActa Oncologica, 2007
- Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- A rational approach to melanoma follow-up in patients with primary cutaneous melanomaBritish Journal of Dermatology, 1999